Clinical Trial Update: First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations [Phase 1, Phase 2]

View source ↗

Summary

This document reports an ongoing first-in-human study of STX-721/PFL-721 in locally advanced or metastatic non-small cell lung cancer with EGFR or HER2 exon 20 …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• PFL-721
• STX-721

Snippet

Sponsor: Pierre Fabre Medicament | Conditions: Non-Small Cell Lung Cancer, NSCLC | Phase 1, Phase 2 | Status: RECRUITING